News

Featured Technology at Celebrate Invention 2018

10/14/2018
FIRST-IN-CLASS THERAPEUTICS – Small-molecule dual inhibitors of the anti-apoptotic Mcl-1 and Bfl-1 proteins for the treatment of cancer. Cancer adapts the ability to evade apoptosis (programmed cell death). The Mcl-1 and Bfl-1 proteins, upregulated in many cancers, block the pro-death response and are key resistance factors. We developed first-in-class dual...

Celebrate Invention 2018

9/26/2018
WEDNESDAY, OCTOBER 17, 1 – 6 PM U-M Innovation Partnerships will host its annual Celebrate Invention event at the Michigan League Ballroom, brief remarks at 3:45 pm with special guests: Kelly Sexton, AVP for Research and Innovative Partnerships Jack Hu, Vice President for Research Andrei Iancu, USPTO Director Mingyan Liu,...

U-M Innovation Partnerships Reports Record Number of New Inventions

10/19/2017
University of Michigan researchers reported 444 new inventions in fiscal year 2017 — up from last year’s 428 — and the fifth straight year of more than 400 inventions from U-M faculty. U-M Innovation Partnerships also had a record 172 U.S. patents issued in FY ’17, up from 135 in...